Glenmark Pharmaceuticals Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
23 Oct 2025
Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40mg/20 mL (2 mg/mL), 150mg/30mL (5 mg/mL), and 200mg/20 mL (10 mg/mL) Single-Dose Vials
Source:
BSE India